Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Howard

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Frontiers in Immunology|October 20, 2022
Decoupling blood telomere length from age in recipients of allogeneic hematopoietic cell transplant in the BMT-CTN 1202Tsung-Po Lai, Simon Verhulst, Casey L Dagnall, et al.
Human Gene Therapy Methods|May 10, 2012
Inhalation of nebulized perfluorochemical enhances recombinant adenovirus and adeno-associated virus-mediated gene expression in lung epitheliumTravis Beckett, Laura Bonneau, Alan Howard, et al.
Retina (Philadelphia, Pa.)|June 3, 2014
Supplementation with three different macular carotenoid formulations in patients with early age-related macular degenerationSarah Sabour-Pickett, Stephen Beatty, Eithne Connolly, et al.
Transplantation and Cellular Therapy|December 27, 2022
Prognostic Biomarkers for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Myeloablative Allogeneic Hematopoietic Cell Transplantation: Results from the Blood and Marrow Transplant Clinical Trials Network 1202 StudySantosh Putta, Bradford A Young, John E Levine, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 4, 2014
Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)C Alan Howard, Marcelo A Fernandez-Vina, Frederick R Appelbaum, et al.
Journal of Alzheimer'S Disease : JAD|November 20, 2014
The impact of supplemental macular carotenoids in Alzheimer's disease: a randomized clinical trialJohn M Nolan, Ekaterina Loskutova, Alan Howard, et al.
The Journal of Antimicrobial Chemotherapy|April 29, 2016
Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trialWilliam W Hope, Thomas J Walsh, Joanne Goodwin, et al.
British Journal of Haematology|June 14, 2016
Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative studyAnita D'Souza, Marcelo Pasquini, Brent Logan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 13, 2019
Follistatin and Soluble Endoglin Predict 1-Year Nonrelapse Mortality after Allogeneic Hematopoietic Cell TransplantationLaura F Newell, Todd E DeFor, Corey Cutler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 9, 2018
Summary of the Second Annual BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune ProfilingSarah A Holstein, J Christine Ye, Alan Howard, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Frontiers in Immunology|October 20, 2022
Decoupling blood telomere length from age in recipients of allogeneic hematopoietic cell transplant in the BMT-CTN 1202Tsung-Po Lai, Simon Verhulst, Casey L Dagnall, et al.
Human Gene Therapy Methods|May 10, 2012
Inhalation of nebulized perfluorochemical enhances recombinant adenovirus and adeno-associated virus-mediated gene expression in lung epitheliumTravis Beckett, Laura Bonneau, Alan Howard, et al.
Retina (Philadelphia, Pa.)|June 3, 2014
Supplementation with three different macular carotenoid formulations in patients with early age-related macular degenerationSarah Sabour-Pickett, Stephen Beatty, Eithne Connolly, et al.
Transplantation and Cellular Therapy|December 27, 2022
Prognostic Biomarkers for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Myeloablative Allogeneic Hematopoietic Cell Transplantation: Results from the Blood and Marrow Transplant Clinical Trials Network 1202 StudySantosh Putta, Bradford A Young, John E Levine, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 4, 2014
Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)C Alan Howard, Marcelo A Fernandez-Vina, Frederick R Appelbaum, et al.
Journal of Alzheimer'S Disease : JAD|November 20, 2014
The impact of supplemental macular carotenoids in Alzheimer's disease: a randomized clinical trialJohn M Nolan, Ekaterina Loskutova, Alan Howard, et al.
The Journal of Antimicrobial Chemotherapy|April 29, 2016
Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trialWilliam W Hope, Thomas J Walsh, Joanne Goodwin, et al.
British Journal of Haematology|June 14, 2016
Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative studyAnita D'Souza, Marcelo Pasquini, Brent Logan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 13, 2019
Follistatin and Soluble Endoglin Predict 1-Year Nonrelapse Mortality after Allogeneic Hematopoietic Cell TransplantationLaura F Newell, Todd E DeFor, Corey Cutler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 9, 2018
Summary of the Second Annual BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune ProfilingSarah A Holstein, J Christine Ye, Alan Howard, et al.
Pageof 9